INTRODUCTION AND OBJECTIVES: Prior studies have
shown that pharmaceutical industry payments may be associated with prescribing habits among physicians. The relationship between payments and prescription of phosphodiesterase type 5 inhibitors (PDE5i) has not been explored. In this study, we evaluated whether industry payments for tadalafil were associated with prescribing habits among urologists (URO) and primary care physicians (PCPs). CONCLUSIONS: There does not appear to be a strong relationship between payments and prescribing habits, which is reassuring regarding the ethics of physician-industry interaction. However, given the presence of a weak association, further study in other samples (e.g. private insurance) and with other PDE5i may be worthwhile.
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Carolyn A. Salter*, Helen Bernie, Denise Asafu-Adjei, Elizabeth Schofield, John P. Mulhall, New York, NY INTRODUCTION AND OBJECTIVES: Platelet-rich plasma (PRP) and low-intensity shock wave therapy (LiSWT) are being touted as treatments for erectile dysfunction (ED) without data on long-term safety and efficacy. These treatments are not covered by insurance and are costly. This study attempted to ascertain what information is provided to potential patients.
METHODS: 10 clinics providing PRP and 10 providing LiSWT for ED were chosen using website directories. All practices selected had a medical physician. Half of the practices were led by a urologist and half by varied other specialties. We attempted to find similar geographic locations and include a mix of major and minor cities. Three scripts were written for candidate patients: one man who had psychogenic ED, one with severe venogenic ED after triple therapy for prostate cancer, and one with likely arteriogenic ED. The scenarios involved the callers identifying themselves as the partners of potential patients, seeking information on whether the men would be good candidates for treatment prior to presenting for evaluation. A standard data collection form was used and 3 different physicians called all 20 practices, 1 provider for each of the 3 clinical scenarios. Vol. 201, No. 4S, Supplement, Saturday, May 4, 2019 THE JOURNAL OF UROLOGY Ò e383
Copyright © 2019 American Urological Association Education and Research, Inc. Unauthorized reproduction of this article is prohibited.
